NUTX — Nutex Health Income Statement
0.000.00%
Last trade - 00:00
- $33.88m
- $276.58m
- $247.65m
- 42
- 92
- 14
- 47
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.37 | 1.59 | 18.8 | 219 | 248 |
Cost of Revenue | |||||
Gross Profit | 0.536 | 0.676 | 4.15 | 13.5 | 34.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.39 | 8.78 | 27.2 | 626 | 279 |
Operating Profit | -7.03 | -7.19 | -8.38 | -407 | -31.8 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.12 | -5.69 | -14.7 | -420 | -48.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.12 | -5.69 | -13.7 | -433 | -43.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -7.12 | -5.65 | -13.7 | -425 | -45.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.12 | -5.65 | -13.7 | -425 | -45.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -195 | -122 | -56.6 | -38.6 | -5.89 |